Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
Edwards Lifesciences (NYSE: EW) has announced it will release its Q4 2024 operating results after market close on February 11, 2025. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the results. Investors can participate by dialing (877) 704-2848 or (201) 389-0893.
The call will be available live and archived in the Investor Relations section of Edwards' website at ir.edwards.com. Edwards Lifesciences is positioned as the global leader in structural heart innovation, focusing on developing breakthrough technologies and maintaining partnerships with healthcare stakeholders.
Edwards Lifesciences (NYSE: EW) ha annunciato che rilascerà i risultati operativi del quarto trimestre 2024 dopo la chiusura del mercato il 11 febbraio 2025. L'azienda ospiterà una conferenza telefonica alle 17:00 ET lo stesso giorno per discutere i risultati. Gli investitori possono partecipare componendo il numero (877) 704-2848 o (201) 389-0893.
La chiamata sarà disponibile in diretta e archiviata nella sezione Relazioni con gli Investitori del sito web di Edwards all'indirizzo ir.edwards.com. Edwards Lifesciences si posiziona come leader globale nell'innovazione del cuore strutturale, concentrandosi sullo sviluppo di tecnologie innovative e mantenendo partnership con i soggetti coinvolti nella sanità.
Edwards Lifesciences (NYSE: EW) ha anunciado que publicará sus resultados operativos del cuarto trimestre de 2024 después del cierre del mercado el 11 de febrero de 2025. La empresa llevará a cabo una conferencia telefónica a las 5:00 p.m. ET el mismo día para discutir los resultados. Los inversores pueden participar llamando al (877) 704-2848 o (201) 389-0893.
La llamada estará disponible en vivo y archivada en la sección de Relaciones con Inversores del sitio web de Edwards en ir.edwards.com. Edwards Lifesciences se posiciona como líder global en innovación del corazón estructural, enfocándose en el desarrollo de tecnologías innovadoras y manteniendo asociaciones con actores del sector salud.
에드워즈 라이프사이언스 (NYSE: EW)는 2025년 2월 11일 시장 마감 후 2024년 4분기 운영 결과를 발표할 것이라고 발표했습니다. 회사는 동일한 날 오후 5:00 (동부 표준시)에 결과를 논의하기 위한 전화 회의를 개최합니다. 투자자는 (877) 704-2848 또는 (201) 389-0893로 전화하여 참여할 수 있습니다.
이번 호출은 에드워즈 웹사이트의 투자자 관계 섹션 ir.edwards.com에서 실시간 및 아카이브로 제공됩니다. 에드워즈 라이프사이언스는 구조적 심장 혁신 분야에서 글로벌 리더로 자리매김하고 있으며, 혁신적인 기술 개발과 의료 이해관계자와의 파트너십 유지를 중심으로 하고 있습니다.
Edwards Lifesciences (NYSE: EW) a annoncé qu'elle publiera ses résultats d'exploitation du quatrième trimestre 2024 après la fermeture des marchés le 11 février 2025. L'entreprise organisera une conférence téléphonique à 17h00 HNE le même jour pour discuter des résultats. Les investisseurs peuvent participer en composant le (877) 704-2848 ou le (201) 389-0893.
La conférence sera disponible en direct et archivée dans la section Relations Investisseurs du site d'Edwards à l'adresse ir.edwards.com. Edwards Lifesciences se positionne comme le leader mondial de l'innovation cardiaque structurelle, se concentrant sur le développement de technologies révolutionnaires et maintenant des partenariats avec les acteurs du secteur de la santé.
Edwards Lifesciences (NYSE: EW) hat angekündigt, dass die Ergebnisse für das 4. Quartal 2024 nach Marktschluss am 11. Februar 2025 veröffentlicht werden. Das Unternehmen wird am selben Tag um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können teilnehmen, indem sie (877) 704-2848 oder (201) 389-0893 anrufen.
Der Anruf wird live und als Archiv in der Investor-Relations-Sektion der Website von Edwards unter ir.edwards.com verfügbar sein. Edwards Lifesciences positioniert sich als globaler Marktführer in der strukturellen Herzinnovationen und konzentriert sich auf die Entwicklung bahnbrechender Technologien sowie auf die Pflege von Partnerschaften mit Akteuren im Gesundheitswesen.
- None.
- None.
To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com.
About Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250204100509/en/
Media Contact: Amy Hytowitz, 949-250-4009
Investor Contact: Mark Wilterding, 949-250-6826
Source: Edwards Lifesciences Corporation
FAQ
When will Edwards Lifesciences (EW) release Q4 2024 earnings?
How can investors join the Edwards Lifesciences (EW) Q4 2024 earnings call?
Where can I find the archived Edwards Lifesciences (EW) Q4 2024 earnings call?
What time is Edwards Lifesciences (EW) Q4 2024 earnings conference call?
